Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes

Published:2019-03 Issue:3 Volume:21 Page:110-118
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Jendle Johan¹,Pöhlmann Johannes²,de Portu Simona³,Smith-Palmer Jayne²,Roze Stéphane⁴

Affiliation:

1. Faculty of Medical Sciences, Örebro University, Örebro, Sweden.

2. Ossian Health Economics and Communications GmbH, Basel, Switzerland.

3. Medtronic International Trading Sàrl, Tolochenaz, Switzerland.

4. HEVA HEOR, Lyon, France.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2018.0328

Reference57 articles.

1. Diabetes Prevalence in Sweden at Present and Projections for Year 2050

2. Severe Hypoglycemia and Mortality After Cardiovascular Events for Type 1 Diabetic Patients in Sweden

3. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

4. Intensive Diabetes Therapy and Ocular Surgery in Type 1 Diabetes

5. Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data;PharmacoEconomics;2024-06-21

2. Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial;Journal of Diabetes Science and Technology;2024-03-17

3. Removing Barriers, Bridging the Gap, and the Changing Role of the Health Care Professional with Automated Insulin Delivery Systems;Diabetes Technology & Therapeutics;2024-03-01

4. The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review;Diabetes Technology & Therapeutics;2024-03-01

5. Advanced Diabetes Technology for Better Glucoregulation, Opportunities and Cost Benefit (“Review on the Reality of a Developing Country”);IFMBE Proceedings;2024